Back

Intra-Cellular Therapies Stock Predictions

3 A.I.-Predicted Stocks to Add to Your Portfolio

Watch Live & FREE Thriving Trends Forecasted by This A.I. Now

Sell

ITCI
Intra-Cellular Therapies

Last Price:

63.22

Seasonality Move:

-4.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Five Top Tech Stocks to Own Now

Click Here to Download the FREE Report

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.
Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $61.32. The Score for ITCI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

66.56

52-Week Low:

42.01

Prediction Charts

Market Cap:

5.88B

Price in USD:

61.32

Volume:

633.41K

Beta:

1.06

Technical Analysis

SMA50:

60.11

SMA100:

53.83

SMA200:

51.82

52-Wk Change:

10.17%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 61.32 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-15	64.50	64.91	65.59	64.21
May-16	63.80	63.14	63.80	61.92
May-17	63.24	63.41	64.15	62.21
May-18	63.50	62.98	64.04	62.18
May-19	63.48	62.42	63.55	62.17
May-22	62.66	62.64	63.23	62.07
May-23	62.59	61.83	63.89	61.42
May-24	61.64	61.00	62.22	60.48
May-25	61.00	60.17	62.16	59.13
May-26	60.07	60.20	60.72	59.77
May-30	60.06	59.43	60.25	59.31
May-31	59.91	59.37	61.00	59.31
Jun-1	59.28	59.53	60.46	58.33
Jun-2	60.09	61.32	61.66	59.03

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.39 per share, an increase this year of $0.59 per share, and an increase next year of $1.60 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.